Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03828227 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters.

Study acronym: COLAGE
StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Sep 30, 2024 to Dec 2025v9
  2. Trial status: Recruiting to Active, Not Recruitingv8 Show 4 more changesShow less
    • Enrollment target: estimated 188 to confirmed 49
    • Primary completion date changed from estimate of Dec 30, 2023 to Nov 10, 2023
    • Start date: Jun 7, 2019 to Jun 14, 2019
    • Site details revised at 22 of 22 sites
  3. Primary endpoint revised
    • Interventions: Capecitabine plus bevacizumab (Drug), OPTIMOX plus bevacizumab (Drug) to Capecitabine plus bevacizumab (Drug), OPTIMOX-bevacizumab (Drug)
    • Secondary endpoints: 5 to 8
    • Study title shortened, about 5 words
    v7
  4. Primary completion date: Aug 30, 2021 to Dec 30, 2023v6
  5. 2 versions Re-verified since Jul 9, 2020, no change to tracked fieldsv4-v5
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 7, 2019 to Jun 7, 2019
    • Study sites: 13 to 22
    v3
  2. Start date: Feb 4, 2019 to Mar 7, 2019v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A national, multicenter, open-label, randomized phase III study. The trial aim is to determine the best therapeutic strategies according with the HRQoL.
Trial Details
NCT Number NCT03828227
Lead Sponsor GERCOR - Multidisciplinary Oncology Cooperative Group
Conditions
(from sponsor)		 Elderly Patients, Metastatic Colorectal Cancer, Quality of Life
Related terms Colorectal Neoplasms
Enrollment 49 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov